Skip to main content

Table 2 Efficacy Analysis (ANCOVA)

From: A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms

Endpoint

Coefficient ± Std Err

p-value

GSRS: Abdominal Pain Subscore

(lower is better)

-0.627 ± 0.307

0.046 †

GSRS: Abdominal Distension Subscore

(lower is better)

-0.572 ± 0.299

0.061 ‡

GSRS: Increased Flatus Subscore

(lower is better)

-0.511 ± 0.353

0.154

GSRS: Total Score

(lower is better)

-4.806 ± 2.381

0.048 †

SODA: Bloating Subscore

(lower is better)

-0.229 ± 0.216

0.294

SODA: Gas Subscore

(lower is better)

-0.348 ± 0.219

0.118

SODA: Non-Pain Symptoms Score

(lower is better)

-1.025 ± 0.870

0.244

SODA: Satisfaction Score

(lower is better)

-0.058 ± 1.358

0.966

SF-36v2: Physical Component Summary

(higher is better)

0.941 ± 1.118

0.403

SF-36v2: Mental Component Summary

(higher is better)

-2.400 ± 2.010

0.238

  1. † Significant (p ≤ 0.05)
  2. ‡Approaches significance (p ~ 0.05)